Biomarker may predict endometrial cancer recurrences

Posted by on May 18, 2016 9:04 pm
Categories: health

The deubiquitinating enzyme USP14 as a promising biomarker for identifying risk of recurrence in endometrial cancer patients, new research suggests.

Leave a Reply

Your email address will not be published. Required fields are marked *